pubmed-article:18809217 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18809217 | lifeskim:mentions | umls-concept:C0034493 | lld:lifeskim |
pubmed-article:18809217 | lifeskim:mentions | umls-concept:C0001527 | lld:lifeskim |
pubmed-article:18809217 | lifeskim:mentions | umls-concept:C1456820 | lld:lifeskim |
pubmed-article:18809217 | lifeskim:mentions | umls-concept:C0683149 | lld:lifeskim |
pubmed-article:18809217 | lifeskim:mentions | umls-concept:C0071097 | lld:lifeskim |
pubmed-article:18809217 | lifeskim:mentions | umls-concept:C1515670 | lld:lifeskim |
pubmed-article:18809217 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
pubmed-article:18809217 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:18809217 | pubmed:dateCreated | 2010-2-1 | lld:pubmed |
pubmed-article:18809217 | pubmed:abstractText | Tumor necrosis factor-alpha (TNF-alpha) is an inflammatory cytokine involved in atherogenesis. Adipose tissue is an important source of endogenous TNF-alpha production. Pioglitazone, a member of the thiazolidinediones (TZDs), has anti-inflammatory and anti-atherogenic properties, while underlying mechanism has not been fully elucidated. The aim of this study was to evaluate the effect of pioglitazone on TNF-alpha serum concentration and mRNA expressions of subcutaneous adipose tissue in hypercholesterolemic rabbits. | lld:pubmed |
pubmed-article:18809217 | pubmed:language | eng | lld:pubmed |
pubmed-article:18809217 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809217 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18809217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18809217 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18809217 | pubmed:month | Jan | lld:pubmed |
pubmed-article:18809217 | pubmed:issn | 1874-1754 | lld:pubmed |
pubmed-article:18809217 | pubmed:author | pubmed-author:ZhaoShui-ping... | lld:pubmed |
pubmed-article:18809217 | pubmed:author | pubmed-author:WuZhi-hongZH | lld:pubmed |
pubmed-article:18809217 | pubmed:author | pubmed-author:ChuLuo-xiangL... | lld:pubmed |
pubmed-article:18809217 | pubmed:author | pubmed-author:YeHui-junHJ | lld:pubmed |
pubmed-article:18809217 | pubmed:copyrightInfo | Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved. | lld:pubmed |
pubmed-article:18809217 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18809217 | pubmed:day | 21 | lld:pubmed |
pubmed-article:18809217 | pubmed:volume | 138 | lld:pubmed |
pubmed-article:18809217 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18809217 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18809217 | pubmed:pagination | 151-6 | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:meshHeading | pubmed-meshheading:18809217... | lld:pubmed |
pubmed-article:18809217 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:18809217 | pubmed:articleTitle | Pioglitazone reduces tumor necrosis factor-alpha serum concentration and mRNA expression of adipose tissue in hypercholesterolemic rabbits. | lld:pubmed |
pubmed-article:18809217 | pubmed:affiliation | Department of Cardiology, The Second Xiangya Hospital of Central South University, Middle Ren-Min road No 139, Changsha, Hunan 410011, PR China. | lld:pubmed |
pubmed-article:18809217 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18809217 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |